Company
United StatesPublic company, NASDAQ: ALDXAldeyra Therapeutics, Inc. (NASDAQ: ALDX), Lexington, MA – FDA Inspections
Inspection records and compliance data for Aldeyra Therapeutics, Inc. in Lexington, Massachusetts. 1 FDA inspection on record, 1 Form 483, last inspected April 28, 2023. Publicly traded as NASDAQ: ALDX.
Company Profile
This profile covers Aldeyra Therapeutics, Inc. based in Lexington, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
Inspected April 28, 2023.
Most cited issue areas
- General responsibilities of sponsors1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 28, 2023 | VAI | Human Drugs · Bioresearch Monitoring | 1204017 |
FDA documents
Form 483s (1)
Other FDA documents (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Lynnfield Drug, Inc. dba Freedom Fertility Pharmacy
Azurity Pharmaceuticals, Inc.
New England Compounding Pharmacy, Inc.
Mandell's Clinical Pharmacy
East Marietta Drug Company
Davis City Pharmacy Inc.
Kohana Pharmacy and Center for Regenerative Medicine Inc.
Lykos Therapeutics, Inc.
Essential Pharmacy Compounding
Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy
Company Information
Name
Aldeyra Therapeutics, Inc.
Stock ticker
ALDX
Exchange
NASDAQ
Share price
$0.63
Market cap
$38.0M
Price as of
November 13, 2026
FEI Number
3013989915
Address
131 Hartwell Ave Ste 320, Lexington, Massachusetts 02421, United States
Country
United States
ID: 1a871130-ca82-4441-a7a4-7d7c28561ffa